D'Liver Overview
- Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
D'Liver General Information
Description
Provider of liver uptake challenges product. The company specialized in distribution and metabolism assays. It also advices on how to accelerate and improve the development of new chemical entities, with special emphasis on biopharmaceuticals.
Contact Information
Primary Industry
Pharmaceuticals
Primary Office
- Post Office Box 6416
- 9294 Tromso
- Norway
+47 930 00 000
D'Liver Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2013 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jun-2011 | Completed | Startup |
D'Liver Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Eskild Endrerud | Chief Executive Officer | ||
| Kjetil Elvevold Ph.D | Co-Founder & Senior Scientist |
D'Liver Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bard Smedsrød Ph.D | Self | Co-Founder, Board Member & Chief Scientific Officer | 000 0000 |
D'Liver Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
D'Liver Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| PreeCap | Venture Capital | Minority | 000 0000 | 000000 0 |